62 related articles for article (PubMed ID: 38473737)
1. Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data.
Ronan K; Jordan E; Leonard C; McDermott R
Ir J Med Sci; 2024 Jun; 193(3):1155-1161. PubMed ID: 37947995
[TBL] [Abstract][Full Text] [Related]
2. Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer.
Parsons HA; Beaver JA; Cimino-Mathews A; Ali SM; Axilbund J; Chu D; Connolly RM; Cochran RL; Croessmann S; Clark TA; Gocke CD; Jeter SC; Kennedy MR; Lauring J; Lee J; Lipson D; Miller VA; Otto GA; Rosner GL; Ross JS; Slater S; Stephens PJ; VanDenBerg DA; Wolff AC; Young LE; Zabransky DJ; Zhang Z; Zorzi J; Stearns V; Park BH
Clin Cancer Res; 2017 Jan; 23(2):379-386. PubMed ID: 27489289
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.
Walsh RJ; Ong R; Cheo SW; Low PQJ; Jayagopal A; Lee M; Ngoi N; Ow SG; Wong ALA; Lim SE; Lim YW; Heong V; Sundar R; Soo RA; Chee CE; Yong WP; Goh BC; Lee SC; Tan DSP; Lim JSJ
Front Oncol; 2024; 14():1342346. PubMed ID: 38812774
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of
Peixoto A; Cirnes L; Carvalho AL; Andrade MJ; Brito MJ; Borralho P; Coimbra N; Borralho PM; Carneiro AS; Castro L; Correia L; Dionísio MR; Faria C; Figueiredo P; Gomes A; Paixão J; Pinheiro M; Prazeres H; Ribeiro J; Salgueiro N; Schmitt FC; Silva F; Silvestre AR; Sousa AC; Almeida-Tavares J; Teixeira MR; André S; Machado JC
Front Mol Biosci; 2023; 10():1082915. PubMed ID: 36825198
[No Abstract] [Full Text] [Related]
5. Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.
Boscolo Bielo L; Belli C; Crimini E; Repetto M; Ascione L; Pellizzari G; Santoro C; Fuorivia V; Barberis M; Fusco N; Rocco EG; Curigliano G
Oncologist; 2024 Jun; 29(6):504-510. PubMed ID: 38520742
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
Mosele MF; Westphalen CB; Stenzinger A; Barlesi F; Bayle A; Bièche I; Bonastre J; Castro E; Dienstmann R; Krämer A; Czarnecka A; Meric-Bernstam F; Michiels S; Miller R; Normanno N; Reis-Filho J; Remon J; Robson M; Rouleau E; Scarpa A; Serrano C; Mateo J; André F
Ann Oncol; 2024 May; ():. PubMed ID: 38834388
[TBL] [Abstract][Full Text] [Related]
7. Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials.
Kim ST; Kim KM; Kim NKD; Park JO; Ahn S; Yun JW; Kim KT; Park SH; Park PJ; Kim HC; Sohn TS; Choi DI; Cho JH; Heo JS; Kwon W; Lee H; Min BH; Hong SN; Park YS; Lim HY; Kang WK; Park WY; Lee J
Oncologist; 2017 Oct; 22(10):1169-1177. PubMed ID: 28701572
[TBL] [Abstract][Full Text] [Related]
8. Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.
Kim J; Park WY; Kim NKD; Jang SJ; Chun SM; Sung CO; Choi J; Ko YH; Choi YL; Shim HS; Won JK;
J Pathol Transl Med; 2017 May; 51(3):191-204. PubMed ID: 28535585
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Molecular Biomarkers: A Paradigm Shift in Diagnostic Pathology.
Dong F
Clin Lab Med; 2024 Jun; 44(2):325-337. PubMed ID: 38821647
[TBL] [Abstract][Full Text] [Related]
10. FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology.
Li D; Kusko R; Ning B; Tong W; Johann DJ; Xu J
Precis Cancer Med; 2021 Dec; 4():. PubMed ID: 35282311
[TBL] [Abstract][Full Text] [Related]
11. Prioritizing Clinically Significant Lung Cancer Somatic Mutations for Targeted Therapy Through Efficient NGS Data Filtering System.
Wang J; Li H; Liu H
AMIA Jt Summits Transl Sci Proc; 2024; 2024():305-313. PubMed ID: 38827108
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsies and those three little words: finding the perfect match for the MTB.
Wahida A; Buschhorn L
Med Genet; 2023 Dec; 35(4):269-273. PubMed ID: 38835735
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
van Geelen CT; Savas P; Teo ZL; Luen SJ; Weng CF; Ko YA; Kuykhoven KS; Caramia F; Salgado R; Francis PA; Dawson SJ; Fox SB; Fellowes A; Loi S
Breast Cancer Res; 2020 Aug; 22(1):91. PubMed ID: 32811538
[TBL] [Abstract][Full Text] [Related]
14. Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study.
Yi Z; Ma F; Liu B; Guan X; Li L; Li C; Qian H; Xu B
BMC Cancer; 2019 May; 19(1):442. PubMed ID: 31088410
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
[TBL] [Abstract][Full Text] [Related]
16.
Fusco N; Malapelle U; Fassan M; Marchiò C; Buglioni S; Zupo S; Criscitiello C; Vigneri P; Dei Tos AP; Maiorano E; Viale G
Front Oncol; 2021; 11():644737. PubMed ID: 33842357
[TBL] [Abstract][Full Text] [Related]
17. Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.
Au TH; Wang K; Stenehjem D; Garrido-Laguna I
J Gastrointest Oncol; 2017 Jun; 8(3):387-404. PubMed ID: 28736627
[TBL] [Abstract][Full Text] [Related]
18. Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
Canino F; Tornincasa A; Bettelli S; Manfredini S; Barbolini M; Moscetti L; Omarini C; Toss A; Tamburrano F; Antonelli G; Baglio F; Belluzzi L; Martinelli G; Natalizio S; Ponzoni O; Dominici M; Piacentini F
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473737
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
